Sale!

DPYS Gene Dihydropyrimidinuria Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DPYS gene dihydropyrimidinuria genetic test is a specialized diagnostic procedure designed to identify mutations in the DPYS gene, which are associated with dihydropyrimidinase deficiency. This condition affects the body’s ability to break down certain components of proteins, leading to a buildup that can cause neurological issues, developmental delays, and other health problems. The test is crucial for early detection and management of the condition.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing a sample of the patient’s DNA to look for specific mutations in the DPYS gene. This analysis helps in confirming the diagnosis of dihydropyrimidinase deficiency, enabling healthcare providers to tailor treatment and management plans for affected individuals.

The cost of the DPYS gene dihydropyrimidinuria genetic test at DNA Labs UAE is set at 4400 AED. While the price might seem significant, the value of the information it provides for the medical management of individuals with dihydropyrimidinase deficiency cannot be understated. Early detection through this test can lead to interventions that significantly improve the quality of life for those affected by this rare genetic condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DPYS Gene Dihydropyrimidinuria Genetic Test

Cost: 4400.0 AED

Test Details:

The DPYS gene is responsible for producing an enzyme called dihydropyrimidinase. Dihydropyrimidinase is involved in the breakdown of certain compounds called pyrimidines, which are building blocks of DNA and RNA.

Dihydropyrimidinuria is a rare genetic disorder characterized by the inability to break down dihydropyrimidines properly, leading to the accumulation of these compounds in the body. This condition can cause various symptoms, including intellectual disability, seizures, developmental delay, and abnormal urine odor.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the case of dihydropyrimidinuria, NGS genetic testing can be used to identify mutations or variations in the DPYS gene that may be responsible for the condition.

By identifying specific genetic changes in the DPYS gene, NGS testing can help confirm a diagnosis of dihydropyrimidinuria and provide information about the specific genetic variant causing the condition. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options in the future.

Test Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for DPYS Gene Dihydropyrimidinuria NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Dihydropyrimidinuria.

Test Name DPYS Gene Dihydropyrimidinuria Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DPYS Gene Dihydropyrimidinuria NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Dihydropyrimidinuria
Test Details

The DPYS gene is responsible for producing an enzyme called dihydropyrimidinase. Dihydropyrimidinase is involved in the breakdown of certain compounds called pyrimidines, which are building blocks of DNA and RNA.

Dihydropyrimidinuria is a rare genetic disorder characterized by the inability to break down dihydropyrimidines properly, leading to the accumulation of these compounds in the body. This condition can cause various symptoms, including intellectual disability, seizures, developmental delay, and abnormal urine odor.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the case of dihydropyrimidinuria, NGS genetic testing can be used to identify mutations or variations in the DPYS gene that may be responsible for the condition.

By identifying specific genetic changes in the DPYS gene, NGS testing can help confirm a diagnosis of dihydropyrimidinuria and provide information about the specific genetic variant causing the condition. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options in the future.